IL6 and cervical carcinoma: In 2017, Zidi et al., (2017) in a case-control study evaluated the effects of IL-6 rs2069845, rs2069840, rs1474348, rs1800795, rs1800797, and rs2069827 polymorphisms with risk of cervical cancer among Tunisian women.